Jade Biosciences, Inc. (JBIO) Operating cash flow 2020–2025
Jade Biosciences, Inc. (JBIO) annual operating cash flow history from SEC filings — net cash provided by operating activities each fiscal year.
-$94.7MFY2025 · since FY2020: -$7.9M → -$94.7M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | -$94.7M | -33.0% |
| FY2024 | -$71.2M | -25.4% |
| FY2023 | -$56.8M | -45.1% |
| FY2022 | -$39.1M | -42.8% |
| FY2021 | -$27.4M | -248.6% |
| FY2020 | -$7.9M | — |
Source: SEC XBRL filings · For reference only · Not investment advice